Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.According ...

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

ACTIVE monitoring may be a safe and effective treatment option for patients with low-risk ductal carcinoma in situ (DCIS), ...

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...

For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive ...

For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...

Tissue Penetration: Consistent with the recently updated trial protocol, tissue Css levels were evaluated in addition to plasma Css levels. The 80 mg/day dose, in both treatment arms, achieved tissue ...

New Delhi: In a major push for the in situ redevelopment of slum and JJ clusters, Delhi Development Authority on Thursday approved an overhaul of the existing policy. During a meeting chaired by ...

Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can ...